Quick Answer
UTAH MEDICAL PRODUCTS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $38.52 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -5.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), UTAH MEDICAL PRODUCTS INC's Revenue From Contract With Customer Excluding Assessed Tax has declined by 2.0%.
- Historical annual values: Fiscal year 2025: $38.52 million | Fiscal year 2024: $40.90 million | Fiscal year 2023: $50.22 million | Fiscal year 2022: $52.28 million | Fiscal year 2021: $49.05 million | Fiscal year 2020: $42.18 million | Fiscal year 2019: $46.90 million | Fiscal year 2018: $42.00 million | Fiscal year 2017: $41.41 million | Fiscal year 2016: $39.30 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: